Morphine-induced spinal release of adenosine is reduced in neuropathic rats

Anesthesiology

Volumn 95, Issue 6, 2001, Pages 1455-1459

  Sandner Kiesling, Andreas ^a   Li, Xinhui ^b   Eisenach, James C ^b  

^a UNIVERSITY OF GRAZ   (Austria)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; DIPYRIDAMOLE; MORPHINE SULFATE; OPIATE;

ANALGESIA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRIFUGATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERSENSITIVITY; LUMBAR SPINAL CORD; MALE; NERVE LIGATION; NEUROPATHY; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SPINAL ANESTHESIA; SPINAL NERVE;

EID: 0035213476     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200112000-00026     Document Type: Article

References (27)

1. Spinal route of analgesia: Opioids and future options
2. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance
3. Exogenous and endogenous adenosine enhance the spinal antiallodynic effects of morphine in a rat model of neuropathic pain
4. Aminophylline differentiates between the depressant effects of morphine on the spinal nociceptive reflex and on the spinal ascending activity evoked from afferent C fibres
5. Spinal adenosine modulates descending antinociceptive pathways stimulated by morphine
6. Involvement of adenosine in the spinal antinociceptive effects of morphine and noradrenaline
7. Spinal opioid receptors and adenosine release: Neurochemical and behavioral characterization of opioid subtypes
8. Morphine releases endogenous adenosine from the spinal cord in vivo
9. Morphine-evoked release of adenosine from the spinal cord occurs via a nucleoside carrier with differential sensitivity to dipyridamole and nitrobenzylthioinosine
10. Spinal and supraspinal mechanisms of neuropathic pain
11. Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists
12. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido [2,3-dlpyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties, II: In vivo characterization in the rat
13. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat
14. Quantitative assessment of tactile allodynia in the rat paw
15. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding
16. Morphine enhances adenosine release from the in vivo rat cerebral cortex
17. Morphine increases depolarization induced purine release from rat cortical slices
18. + release purines from capsaicin-sensitive primary afferent nerve terminals in the spinal cord
19. 2+-channels to release adenosine from spinal cord synaptosomes
20. Multiple receptors involved in peripheral alpha 2, mu, A1 antinociception, tolerance, and withdrawal
21. Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury
22. The control of the metabolism and the hormonal role of adenosine
23. Time-dependent antinociceptive interactions between opioids and nucleoside transport inhibitors
24. The effect of adenosine receptor agonists on analgesic effects of morphine
25. An open label trial of the possible analgesic effects of dipyridamole
26. Theophylline antagonizes cardiovascular responses to dipyridamole in man without affecting increases in plasma adenosine
27. Changes in pial arteriolar diameter and CSF adenosine concentrations during hyoxia